Technical Comparison
PharmaCyte Biotech, Inc. - Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between PMCB and NVDA.
Primary Asset
PMC
PharmaCyte Biotech, Inc. - Common Stock
Market Rank #1003826Live Price$0.38
Market Capitalization$4.1M
24h Change+12.03%
Circulating Supply11M PMCB
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$200.13
Market Capitalization$4.8T
24h Change-3.17%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | PMCB Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1003826 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $0.38 | $200.13 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $4.1M | $4.8T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is PharmaCyte Biotech, Inc. - Common Stock bigger than NVIDIA Corporation - Common Stock?
PharmaCyte Biotech, Inc. - Common Stock has a market cap of $4.1M, while NVIDIA Corporation - Common Stock sits at $4.8T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between PharmaCyte Biotech, Inc. - Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 PMCB is worth 0.001904 NVDA.